Inspire Medical Systems: Hold Rating Amidst Limited Revenue Upside and Slow Inspire V Launch
Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...
Inspire Medical price target lowered to $190 from $200 at Stifel
Stifel lowered the firm’s price target on Inspire Medical (INSP) to $190 from $200 and keeps a Hold rating on the shares. The firm notes in ...
Lifesaving medical devices being built in Bedford, Massachusetts
On the surface, making medical devices may not sound very exciting. But when you take a closer look, as in at the cellular level, it is quite remarkable.